Strategic

HRV Pharma acquires Phatebo

Pharmaceutical wholesale, clinical trial medication · Hilzingen, Germany

SourcingClub was not involved in this transaction.

HRV Pharma acquires 100% of Phatebo GmbH from ZeroStack Corp. Phatebo is a licensed pharmaceutical wholesaler in Hilzingen that supplies investigational and comparator products for clinical trials.

bwhealthcareworld.com

How the deal fits together.

  1. ZeroStack CorpSeller
  2. PhateboTarget
  3. HRV PharmaBuyer

Who was involved.

Buyer
HRV Pharma
Target
Phatebo, Hilzingen
Seller
ZeroStack Corp
Type
Strategic
Country
Germany
First reported
04/11/2026

Deal-Radar no. 46-004 · added in Week 46/2026, first reported on 04/11/2026 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Method

Valuation in this industry.

5.9 to 10.0times EBITDA

  • 5.9x to 7.6xRevenue under €5m
  • 7.0x to 9.0x€5m to €50m
  • 8.2x to 10.0xover €50m

Market range for Healthcare & Medical Technology, not the price of this deal. Data basis: DUB KMU-Multiples, Q3/2026; preparation: SourcingClub.

November 2026 on the Deal-Radar.

48 of 109 deals so far are of the type Strategic.

  1. Strategic48
  2. Add-on16
  3. Carve-out14
  4. Funding round14
  5. Insolvency8
  6. Buy-out4
  7. Minority stake3
  8. Merger1
  9. Secondary1

New deals every morning. By email on Mondays.

All deals of the previous week in one email, with source and adviser.

Weekly email every Monday, in German.

Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 9 November 2026.